Enokizumab
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Humanized (from mouse) |
Target | IL9 |
Clinical data | |
ATC code |
|
Identifiers | |
ChemSpider |
|
UNII | |
KEGG | |
Chemical and physical data | |
Formula | C6492H10000N1704O2038S44 |
Molar mass | 148.4 kg/mol |
|
Enokizumab is a humanized monoclonal antibody designed for the treatment of asthma.[1]
Enokizumab was developed by MedImmune.
References
IL-1 |
| ||||
---|---|---|---|---|---|
IL-2 |
| ||||
IL-3 |
| ||||
IL-4 |
| ||||
IL-5 |
| ||||
IL-6 |
| ||||
IL-7 |
| ||||
IL-8 |
| ||||
IL-9 |
| ||||
IL-10 |
| ||||
IL-11 |
| ||||
IL-12 |
| ||||
IL-13 |
| ||||
IL-15 |
| ||||
IL-17 |
| ||||
IL-18 |
| ||||
IL-20 |
| ||||
IL-21 |
| ||||
IL-22 |
| ||||
IL-23 |
| ||||
IL-27 |
| ||||
IL-28 |
| ||||
IL-31 |
| ||||
IL1RL1 |
| ||||
IL1RL2 |
| ||||
Others |
| ||||
|
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.